Antiemetic Fosaprepitant To Remedy Nausea and Vomiting: A Randomized Control Trial
Conditions: Nausea and Vomiting; Nausea; Vomiting Interventions: Drug: Fosaprepitant 150 mg; Drug: Ondansetron 4 mg Sponsors: Montefiore Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
Comparative Study on the Efficacy and Safety of Ondansetron Oral Membrane for the Prevention of Vomiting During Moderate Hypoemetic Chemotherapy
Conditions: To Analyze and Compare the Efficacy and Safety of Ondansetron and Tablet for the Prevention of Moderate and Hypoemetic Chemotherapy Interventions: Drug: Ondansetron oral membrane Sponsors: Shanghai Children ' s Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Ondansetron Use for Preventing Pruritus In Patients Undergoing Cesarean Section
Conditions: Pruritus Caused by Drug Interventions: Drug: Ondansetron 8mg Sponsors: Wayne State University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
Dexmedetomidine Compared to Ondansetron for Postanaesthetic Shivering in Patients Undergoing a Cesarean Section
Conditions: Postanesthetic Excitement; Cesarean Section Interventions: Drug: saline solution Sponsors: Hospital Central " Dr. Ignacio Morones Prieto " Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
the Efficacy and Safety of Ondansetron Oral Soluble Pellicles
Conditions: Nausea and Vomiting Interventions: Drug: Ondansetron Oral Soluble Pellicles Sponsors: The First Affiliated Hospital of Xinxiang Medical College Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Caesarean Section
Conditions: Ondansetron Lozenge; Postoperative Nausea and Vomiting; Caesarean Section Interventions: Drug: Ondansetron lozenge (Ondalenz ©); Drug: Ondansetron IV Sponsors: Tanta University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children
Conditions: Pediatric Solid Tumor, Unspecified, Protocol Specific Interventions: Drug: Ondansetron (Oral soluble film OR injections) ,Dexamethasone Sponsors: Yizhuo Zhang Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Granisetron Versus Ondansetron for Nausea and Vomiting in Pediatric Age Group
Conditions: Nausea and Vomiting in Pediatric Age Group Interventions: Drug: Ondansetron Oral Film; Drug: Granisetron Oral Liquid Product Sponsors: Ain Shams University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade
Conditions: Nausea With Vomiting Chemotherapy-Induced Interventions: Drug: Ondansetron every 3 weeks; Drug: Aprepitant; Drug: Dexamethasone; Drug: Ondansetron weekly Sponsors: Hubei Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
Prophylaxis Against Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
Conditions: Postoperative Nausea and Vomiting; Laparoscopic Cholecystectomy Interventions: Drug: Ondansetron 4mg + dexmedetomidine 0.5 ug/kg + normal saline .; Drug: Ondansetron 4mg + dexamethasone 8mg + normal saline. Sponsor: Tanta University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials
